Gallium nitrate

Phase 1Radiopharmaceutical

GGenta Incorporated

Gallium nitrate is one of 43 small molecule programs targeting Cystic Fibrosis. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cystic FibrosisRecruiting

Cystic FibrosisPhase 1

Recruiting

Competition

Competitive Landscape

107 competitors in Cystic Fibrosis

#DrugCompanyPhaseTrials

Ibsrela

AArdelyx

Phase 3

1 2

HSK31858

Haisco Pharmaceutical Group Co., Ltd.

Phase 3

2 3

Tygacil

PPrism Pharmaceuticals

Phase 2

1 4

Amoxil

GGlobal Antibiotics Research and Development Partnership

Phase 2

1 5

ELX/TEZ/IVA

Vertex Pharmaceuticals

Phase 3

18 6

Trimethoprim-Sulfamethoxazole

Astellas

Phase 2

1 7

Trikafta

NNottingham University Hospitals NHS Trust

Phase 3

4 8

VNZ/TEZ/D-IVA

Vertex Pharmaceuticals

Phase 3

1 9

VX-121/TEZ/D-IVA

Vertex Pharmaceuticals

Phase 3

4 10

Hyperpolarized Xenon-129

TThunder Bay Regional Health Research Institute

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 1Recruiting

Cystic Fibrosis

NCT04294043

Clinical

Trials by Indication[1]

Lymphoma2 trials

Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

Completed·GGenta Incorporated·Phase 2·NCT00054808·40 enrolled

Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Completed·RRoswell Park Cancer Institute·Phase 2·NCT00002578·35 enrolled

Cystic Fibrosis2 trials

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

Recruiting·CChris Goss·Phase 1·NCT04294043·40 enrolled

A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)

Completed·UUniversity of Washington·Phase 2·NCT02354859·119 enrolled

Rhabdomyosarcoma1 trial

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

Completed·MMedical College of Wisconsin·Phase 1·NCT00002543·3 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Gallium nitrate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Gallium nitrate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Gallium nitrate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Genta Incorporated company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Radiopharmaceutical[2]
Highest Phase: Phase 1[1]
Company: GGenta Incorporated

Gallium nitrate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Lymphoma2 trials

Cystic Fibrosis2 trials

Rhabdomyosarcoma1 trial

References

Drug Info

Quick Facts

Related News